CCRM Australia has partnered with local and international venture capital firms to launch the International Regenerative Medicine SuperPitch. The SuperPitch offers expertise and investment funding for translation and commercialisation of Australian regenerative medicine and related projects. CCRM Australia’s SuperPitch IV extends to CCRM Hubs in Canada, the Netherlands and the Nordic States.
The International Regenerative Medicine SuperPitch IV provides an opportunity for companies and researchers to showcase their technologies or ideas. Expert feedback, commercialisation support from CCRM Australia and, for suitable projects, further development funding will be made available. The participation of partners with expertise in various specialties and lifecycle stages empowers the SuperPitch to streamline progress from proof of concept through to clinical trials.
Learn more about the CCRM Australia International Regenerative Medicine SuperPitch IV.